Rhythm Pharmaceuticals, Inc.RYTMNASDAQ
LOADING
|||
Operating Income Growth Under Pressure
Trending lower, below historical average, slight contraction.
Left:
||||
Year-over-year operating income growth rate
Latest
-16.24%
↓ 22% below average
Average (39q)
-13.34%
Historical baseline
Range
High:71.06%
Low:-239.00%
CAGR
-4.0%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -16.24% |
| Q2 2025 | 3.63% |
| Q1 2025 | -13.94% |
| Q4 2024 | 5.99% |
| Q3 2024 | -8.42% |
| Q2 2024 | 71.06% |
| Q1 2024 | -239.00% |
| Q4 2023 | 6.12% |
| Q3 2023 | 5.69% |
| Q2 2023 | 11.28% |
| Q1 2023 | -24.77% |
| Q4 2022 | -7.22% |
| Q3 2022 | 12.93% |
| Q2 2022 | 14.41% |
| Q1 2022 | -3.34% |
| Q4 2021 | -15.26% |
| Q3 2021 | -9.42% |
| Q2 2021 | -17.54% |
| Q1 2021 | 1.92% |
| Q4 2020 | -2.30% |
| Q3 2020 | -7.41% |
| Q2 2020 | 9.58% |
| Q1 2020 | -3.14% |
| Q4 2019 | 7.77% |
| Q3 2019 | 15.95% |
| Q2 2019 | -44.66% |
| Q1 2019 | -12.41% |
| Q4 2018 | -41.09% |
| Q3 2018 | -28.11% |
| Q2 2018 | 11.65% |
| Q1 2018 | -54.79% |
| Q4 2017 | -32.55% |
| Q3 2017 | -22.68% |
| Q2 2017 | -5.71% |
| Q1 2017 | 23.71% |
| Q4 2016 | -30.84% |
| Q3 2016 | -11.55% |
| Q2 2016 | -6.44% |
| Q1 2016 | 4.47% |
| Q4 2015 | -80.87% |